Skip to content

75+ Cancer Screener (75+CS)

SCREENING FOR BREAST, COLORECTAL AND PROSTATE CANCER IN 75+ YEARS OLD PATIENTS (ALSO APPLICABLE FOR 65+)
This instrument may be reapplied whenever indicated.
Discipline of Geriatrics and Gerontology, Department of Medicine. Paulista School of Medicine (EPM), Federal University of São Paulo (UNIFESP). São Paulo, Brazil.
Authors: Marianne Wolff Rezende Teixeira, MD (UNIFESP); Matheus de Oliveira Barros, MD (UNIFESP); Luciano Pereira Soares, PhD (Insper); Adriana Bruscato Bortoluzzo, PhD (Insper); Maysa Seabra Cendoroglo, MD, PhD (UNIFESP); Gisele Wally Braga Colleoni, MD, PhD (UNIFESP)
Contributors: Maísa Braga Aguiar, MD (UNIFESP); Lia Alexandre Botelho de Paula, MD (UNIFESP); Ana Beatriz Galhardi Di Tommaso, MD, MSc (UNIFESP); Eduardo Canteiro Cruz, MD (UNIFESP)
Fluxograma de rastreio

Step of 5

CFS: FRIED: Dementia: 10-year mortality risk: Consent:
No data is stored or retained. Prognostic tools support, they do not replace, clinical judgment.
References
  1. Cruz M, Covinsky K, Widera EW, Stijacic-Cenzer I, Lee SJ. Predicting 10-year mortality for older adults. JAMA. 2013;309(9):874-876. doi: 10.1001/jama.2013.1184. PMID: 23462780; PMCID: PMC3760279.
  2. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al.; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(4):601 (Erratum to: 2019;48(1):16-31). doi: 10.1093/ageing/afz046. PMID: 31081853; PMCID: PMC6593317.
  3. Deardorff WJ, Barnes DE, Jeon SY, Boscardin WJ, Langa KM, Covinsky KE, et al. Development and External Validation of a Mortality Prediction Model for Community-Dwelling Older Adults With Dementia. JAMA Intern Med. 2022;182(11):1161-1170. doi: 10.1001/jamainternmed.2022.4326. PMID: 36156062; PMCID: PMC9513707.
  4. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, et al.; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-M156. doi: 10.1093/gerona/56.3.m146. PMID: 11253156.
  5. Kim DH, Rockwood K. Frailty in Older Adults. N Engl J Med. 2024;391(6):538-548. doi: 10.1056/NEJMra2301292. PMID: 39115063; PMCID: PMC11634188.
  6. Kim EE, Cenzer I, Graham FJ, Kang J, Lee SJ, Rustagi AS. Time to Benefit for Lung Cancer Screening: A Systematic Review and Survival Meta-Analysis. Am J Prev Med. 2025;69(2):107736. doi: 10.1016/j.amepre.2025.107736. PMID: 40447235; PMCID: PMC12370011.
  7. Kotwal AA, Walter LC. Cancer Screening in Older Adults: Individualized Decision-Making and Communication Strategies. Med Clin North Am. 2020;104(6):989-1006. doi: 10.1016/j.mcna.2020.08.002. PMID: 33099456; PMCID: PMC7594102.
  8. Lee SJ, Boscardin WJ, Kirby KA, Covinsky KE. Individualizing life expectancy estimates for older adults using the Gompertz Law of Human Mortality. PLoS One. 2014;9(9):e108540. doi: 10.1371/journal.pone.0108540. PMID: 25265291; PMCID: PMC4180452.
  9. Lee SJ, Boscardin WJ, Stijacic-Cenzer I, Conell-Price J, O'Brien S, Walter LC. Time lag to benefit after screening for breast and colorectal cancer: meta-analysis of survival data from the United States, Sweden, United Kingdom, and Denmark. BMJ. 2013;346:e8441. doi: 10.1136/bmj.e8441. PMID: 23299842; PMCID: PMC4688425.
  10. Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, Mitnitski A. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489-495. doi: 10.1503/cmaj.050051. PMID: 16129869; PMCID: PMC1188185.
  11. Rockwood K, Theou O. Using the Clinical Frailty Scale in Allocating Scarce Health Care Resources. Can Geriatr J. 2020;23(3):210-215. doi: 10.5770/cgj.23.463. PMID: 32904824; PMCID: PMC7458601.